What is Alnylam Pharmaceuticals's price / earnings?

Alnylam Pharmaceuticals (ALNY) reported price / earnings of 87.4× in Q1 2026.

What does price / earnings mean?

How many dollars investors pay for each dollar of the company's annual profit.

How do you interpret price / earnings?

Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.

How does price / earnings compare across companies?

Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.

Alnylam Pharmaceuticals ALNY Price / earnings

Price / earnings at other companies

ModernaMRNA

38.4×+34.3×

Roivant SciencesROIV

249.7×+248×

United TherapeuticsUTHR

20.2×+8.8×

IncyteINCY

13.1×-538×

AmgenAMGN

24.3×-3.9×

Royalty PharmaRPRX

24.8×+12.5×

Other financials

Income statement

See full

Revenue$1.2B+96.4%

Gross profit$959.7M+83.1%

Operating income$268.6M+1,386%

Net income$206.0M+1,229%

EPS (diluted)$1.51+1,179%

Balance sheet

See full

Cash & equivalents$1.7B+67.5%

Total debt$263.7M-4.5%

Total equity$1.1B+152%

Total assets$5.1B+21.7%

Cash flow

See full

Operating cash flow$70.5M+159%

CapEx$21.8M+143%

Free cash flow$48.7M+138%

Valuation

See full

Market cap$37.75B+25.6%

Enterprise value$36.3B+24.1%

P/S8.8×-4.0×

Profitability

See full

Gross margin81%-5.3pp

Operating margin17.5%+14.4pp

Net margin11.7%+8.0pp

Returns & leverage

See full

Return on equity66.9%—

Debt / equity0.2×-0.4×

Current ratio3.1×+0.1×

Where this comes from

Calculated from Alnylam Pharmaceuticals’s reported figures.

market cap/net income=87.4×

Based on the most recent quarter.

The official record: Alnylam Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alnylam Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alnylam Pharmaceuticals's price / earnings?: Alnylam Pharmaceuticals (ALNY) reported price / earnings of 87.4× in Q1 2026.
What does price / earnings mean?: How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?: Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?: Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.